Education
About Us
Working with TipRanks
Follow Us
Gufic Biosciences Limited (IN:GUFICBIO)
:GUFICBIO
RESEARCH TOOLSreports
Total Valuation
Gufic Biosciences Limited has a market cap or net worth of ₹36.63B. The enterprise value is ₹41.42B.
Market Cap₹36.63B
Enterprise Value₹41.42B
Share Statistics
Gufic Biosciences Limited has 100,277,504 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding100,277,504
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Gufic Biosciences Limited’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 8.69%.
Return on Equity (ROE)0.12
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)8.69%
Return on Capital Employed (ROCE)0.15
Revenue Per Employee5.50M
Profits Per Employee467.13K
Employee Count1,491
Asset Turnover0.70
Inventory Turnover2.41
Valuation Ratios
The current PE Ratio of Gufic Biosciences Limited is 59.2. Gufic Biosciences Limited’s PEG ratio is ―.
PE Ratio59.2
PS Ratio―
PB Ratio―
Price to Fair Value5.63
Price to FCF―
Price to Operating Cash Flow0.00
PEG Ratio―
Income Statement
In the last 12 months, Gufic Biosciences Limited had revenue of 8.20B and earned 696.50M in profits. Earnings per share was 6.96.
Revenue8.20B
Gross Profit2.97B
Operating Income1.14B
Pretax Income941.43M
Net Income696.50M
EBITDA1.38B
Earnings Per Share (EPS)6.96
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Gufic Biosciences Limited pays an annual dividend of ₹0.1, resulting in a dividend yield of 0.03%
Dividend Per Share₹0.1
Dividend Yield0.03%
Payout Ratio1.62%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.92
52-Week Price Change-9.45%
50-Day Moving Average367.22
200-Day Moving Average386.06
Relative Strength Index (RSI)41.11
Average Volume (3m)13.65K
Important Dates
Gufic Biosciences Limited upcoming earnings date is Nov 13, 2025, TBA (Confirmed).
Last Earnings DateAug 13, 2025
Next Earnings DateNov 13, 2025
Ex-Dividend DateSep 22, 2025
Financial Position
Gufic Biosciences Limited as a current ratio of 1.61, with Debt / Equity ratio of 55.93%
Current Ratio1.61
Quick Ratio1.05
Debt to Market Cap0.09
Net Debt to EBITDA2.22
Interest Coverage Ratio4.92
Taxes
In the past 12 months, Gufic Biosciences Limited has paid 244.95M in taxes.
Income Tax244.95M
Effective Tax Rate0.26
Enterprise Valuation
Gufic Biosciences Limited EV to EBITDA ratio is 26.70, with an EV/FCF ratio of 136.28.
EV to Sales4.50
EV to EBITDA26.70
EV to Free Cash Flow136.28
EV to Operating Cash Flow35.98
Balance Sheet
Gufic Biosciences Limited has ₹193.96M in cash and marketable securities with ₹0.00 in debt, giving a net cash position of -₹193.96M billion.
Cash & Marketable Securities₹193.96M
Total Debt₹0.00
Net Cash-₹193.96M
Net Cash Per Share-₹1.93
Tangible Book Value Per Share₹60.09
Margins
Gross margin is 49.55%, with operating margin of 13.86%, and net profit margin of 8.50%.
Gross Margin49.55%
Operating Margin13.86%
Pretax Margin11.48%
Net Profit Margin8.50%
EBITDA Margin16.87%
EBIT Margin14.30%
Analyst Forecast
The average price target for Gufic Biosciences Limited is ₹376.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target₹376.00
Price Target Upside5.92% Upside
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast2.37%
EPS Growth Forecast-30.78%